1. Home » 
  2. Quarterly Results » 
  3. Trident Texofab Q2 Results Total Income Reaches ₹2,921.32 Lakhs

Trident Texofab Q2 Results Total Income Reaches ₹2,921.32 Lakhs

Trident Texofab Q2 Results Revenue from Operations at ₹2,644.84 Lakhs, an increase from ₹2,571.21 Lakhs, and Total Income for Q2 was ₹2,921.32 Lakhs, compared to ₹2,657.50 Lakhs in the previous quarter.

by Ruksana

Updated Oct 14, 2024

Article continues below advertisement
Trident Texofab Q2 Results Total Income Reaches ₹2,921.32 Lakhs

Trident Texofab Q2 Results

Trident Texofab is a textile company that provides financial results for different time periods, showing how well it performed. In the quarter that ended on September 30, 2024, the company made about ₹2,644.84 Lakhs from operations, which is higher than the ₹2,571.21 Lakhs made in the previous quarter and also higher than ₹2,320.27 Lakhs from the same quarter last year. They also earned ₹276.48 Lakhs from other income sources, which is a significant increase compared to ₹86.30 Lakhs in the last quarter and ₹103.21 Lakhs in the same quarter last year.

Trident Texofab's total income for this quarter was ₹2,921.32 Lakhs, compared to ₹2,657.50 Lakhs last quarter and ₹2,423.48 Lakhs last year. However, their expenses also increased, reaching ₹2,826.50 Lakhs this quarter. The main costs were for materials and stock purchases, but they managed to keep some profit. They had a profit before tax of ₹94.82 Lakhs. After accounting for tax expenses, their final profit for this quarter was ₹100.41 Lakhs. 

Here's a simplified table format for the financial results you provided, presented in a clear and organized way:

(Amount in Lakhs)

Particulars

30-09-2024 (Unaudited)

30-06-2024 (Unaudited)

30-09-2023 (Unaudited)

Revenue

     

Revenue From Operations

2,644.84

2,571.21

2,320.27

Other Income

276.48

86.30

103.21

Total Income

2,921.32

2,657.50

2,423.48

Expenses

     

Cost of materials consumed

535.59

379.18

512.05

Purchases of Stock-in-Trade

1,674.31

1,736.38

1,535.30

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

183.98

105.52

-79.56

Employee Benefit Expenses

75.72

65.81

68.46

Finance Costs

112.95

105.26

106.75

Depreciation and Amortization expense

41.24

41.15

41.10

Other Expenses

202.70

132.19

158.16

Total Expenses

2,826.50

2,565.49

2,342.26

Profit/loss Before exceptional items and Tax (III-IV)

94.82

92.01

81.22

Exceptional Items

-

-

3.29

Profit/(Loss) before tax (V-VI)

94.82

92.01

81.22

Tax Expense

-

-

-

(1) Current Tax

-

-

-

(2) Deferred Tax (net)

-

-

-

Total Tax Expense

-

-

-

Profit/(loss) for the period from continuing operation (VII-VIII)

100.41

69.56

75.32

Profit/(loss) from discontinued operations

-

-

-

Profit/(loss) for the period (IX+XII)

100.41

69.56

75.32

Source: Here 

For More Quarterly Results check our Twitter Page

Visit our website for more Quarterly results

Article continues below advertisement
Article continues below advertisement

Trident Texofab Financial Metrics

Trident Texofab’s market cap is ₹51.3 crore, which means that's the total value of all its shares. The current price of the stock is ₹51.0 per share. It reached a high of ₹71.9 and a low of ₹36.2 in the past. The Stock P/E ratio of 24.2 indicates how much investors are willing to pay for each unit of earnings. The book value is ₹17.8, which represents the company's net asset value. The dividend yield is 0%, meaning the company doesn't pay dividends. ROCE (Return on Capital Employed) is 12.2%, and ROE (Return on Equity) is 5.47%, showing how effectively the company uses its capital and equity to generate profits. 

Here’s the financial information you provided, formatted in a simple table:

Parameter

Value

Market Cap

₹ 51.3 Cr.

Current Price

₹ 51.0

High / Low

₹ 71.9 / ₹ 36.2

Stock P/E

24.2

Book Value

₹ 17.8

Dividend Yield

0.00 %

ROCE

12.2 %

ROE

5.47 %

Face Value

₹ 10.0

Article continues below advertisement
Article continues below advertisement

Quarterly Results 

Trident Texofab is a company that focuses on manufacturing and selling textiles, especially fabrics. The table shows important financial details about the company. The market cap is ₹51.3 crore, which means that's the total value of all its shares. The current price of the stock is ₹51.0 per share. It reached a high of ₹71.9 and a low of ₹36.2 in the past. The Stock P/E ratio of 24.2 indicates how much investors are willing to pay for each unit of earnings. The book value is ₹17.8, which represents the company's net asset value. 

Here’s a table for Mar 2024, Jun 2024, and Sep 2024, along with a detailed summary for each quarter:

(Rs. in crores)

Metric

Mar 2024

Jun 2024

Sep 2024

Sales

30.17

25.71

26.45

Expenses

29.15

24.19

26.72

Operating Profit

1.02

1.52

-0.27

OPM (%)

3.38%

5.91%

-1.02%

Other Income

0.39

0.86

2.76

Interest

1.14

1.05

1.13

Depreciation

0.41

0.41

0.41

Profit Before Tax

-0.14

0.92

0.95

Tax (%)

-28.57%

25.00%

-6.32%

Net Profit

-0.10

0.70

1.00

EPS (in Rs)

-0.10

0.70

0.99

Article continues below advertisement
Article continues below advertisement

About Trident Texofab

Trident Texofab is a textile company that started in 2008. It began as a trading business, selling home furnishing items like bedsheets, curtains, and upholstery. The company also sold other textile products, including scarves, pareos, suits, and shirting. Over the years, Trident Texofab grew steadily and became well-known for its quality. In 2017, the company went public and offered shares on the Bombay Stock Exchange (BSE) to help expand its operations.

In 2018, it started its first manufacturing plant in Surat, Gujarat, producing grey fabrics and finished garments. The company also offers services like embroidery, stitching, and digital printing. Today, Trident Texofab produces a variety of home furnishings, garments, and technical textiles, with an annual manufacturing capacity of about 25 million meters. The company continues to plan for more growth and expansion in the textile industry.


Trident Texofab Q2 Results - FAQs

1. What was Trident Texofab's revenue from operations for Q2 2024?  

Trident Texofab's revenue from operations for Q2 2024 was ₹2,644.84 million.

2. How much did Trident Texofab earn from other income in Q2 2024?  

Trident Texofab earned ₹276.48 million from other income in Q2 2024.

3. What was Trident Texofab's total income for Q2 2024?

Trident Texofab's total income for Q2 2024 was ₹2,921.32 million.

4. What were Trident Texofab's total expenses in Q2 2024?

Trident Texofab's total expenses in Q2 2024 were ₹2,826.50 million.

5. What was Trident Texofab's profit before tax for Q2 2024?

Trident Texofab's profit before tax for Q2 2024 was ₹94.82 million.

6. What was Trident Texofab's final profit for Q2 2024 after tax?

Trident Texofab's final profit after tax for Q2 2024 was ₹100.41 million.

7. What was Trident Texofab's market capitalization?

Trident Texofab's market capitalization is ₹51.3 crore.

8. What is Trident Texofab's ROCE?

Trident Texofab's Return on Capital Employed (ROCE) is 12.2%.

9. What is Trident Texofab's ROE?  

Trident Texofab's Return on Equity (ROE) is 5.47%.

10. What were Trident Texofab's sales figures for Q2 2024?  

Trident Texofab's sales figures for Q2 2024 were ₹26.45 crores.

Disclaimer : The above information is for general informational purposes only. All information on the Site is provided in good faith, however we make no representation or warranty of any kind, express or implied, regarding the accuracy, adequacy, validity, reliability, availability or completeness of any information on the Site.